The lower panel Western blot in [Figure 2A](#pone-0115927-g001){ref-type="fig"} is incorrect. The authors have provided a corrected [Figure 2](#pone-0115927-g001){ref-type="fig"} here.

![Study of proteosome and caspase-3 activities in aspirin-treated platelets (A), Western blots showing expression level of active Bax in platelets pretreated with ethanol, aspirin, ABT737, epoxomicin, PSI and bortezomib, as indicated (upper panel) normalized against β-actin (lower panel).\
(B), Quantitative representation of active Bax levels in platelet whole cell lysates determined by densitometry of Western blots. (C), caspase-3 activity from the extent of cleavage of fluorigenic substrate AC-DEVD-AMC. (D), Assay of proteasome enzymatic activity in platelets pretreated with ethanol, PSI (proteasome inhibitor) (10 µM) and aspirin. Data are representative of five different experiments and expressed as mean±SD. (\*p\<0.05 as compared to ethanol-pretreated resting platelets).](pone.0115927.g001){#pone-0115927-g001}
